be visible on the BioBusiness market ISSN 2300-0228

Log in | Register

Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer
Impressions from the visit to Wageningen, the specter of famine, CRISPR Cas9 to the rescue!
Reach out to potential partners and customers in the Danish-Swedish life science cluster, Medicon Valley
Central European Healthcare Expo (20-21.05.2020 Global Expo Warsaw)
The world of healthcare ...

All articles

Filters:

Tag: radiopharmaceuticals

Show search box

2015-09-09

IASOcholine radiotracer export to the Czech Republic and Slovakia

IASOcholine radiotracer export to the Czech Republic and Slovakia

Synektik Group - a leading provider of innovative products, services and IT solutions for diagnostic imaging and nuclear medicine - begins delivery of a special radiotracer, IASOcholine, to the Czech Republic and Slovakia. PET-CT imaging using Choline radiotracer is one of the most modern methods use... Read more

Tags cancer , radiopharmaceuticals , diagnostics

2013-12-02

Synektik SA enters a market worth $2,000,000,000

Synektik SA enters a market worth $2,000,000,000

Synektik SA – a leader in providing innovative products, services and IT solutions for diagnostic imaging and nuclear medicine signed the $4,000,000 contract for licenses and joint research and development with the Israel company Hadasit Medical Resarch & Development Ltd. On the basis of the agreeme... Read more

Tags collaboration , Synektik , radiopharmaceuticals , PET , cardiac diseases , Cezary Dariusz Kozanecki